The Prescription Drug User Fee Act (PDUFA) target action date is May 10, 2023 PRINCETON, N.J. & DEERFIELD, Ill.–(BUSINESS WIRE)–Otsuka Pharmaceutical Development...
KUALA LUMPUR–(BUSINESS WIRE)–#Analytics–Fusionex has partnered with International Medical University (IMU) in a mutual collaborative program known as Personalized Learning Analytics. This pilot...
LOS ANGELES–(BUSINESS WIRE)–#COVID19–A Washington Post investigation has revealed an ambitious effort by China to expand its biotechnology sector significantly, with sometimes controversial...
Drive India-US business relationship 5-city roadshow planned from April 23 to May 2 – Princeton, NJ; Boston, MA; Atlanta, GA; Dallas, TX;...
A comprehensive investor-focused overview offers key insights into the company�s financials, management team, and investment thesis. The release of these in-depth investor...
BEIJING–(BUSINESS WIRE)–The global finals of the 21st “Chinese Bridge” Chinese Proficiency Competition for Foreign College Students will be broadcast on CCTV-4 from...
TAIPEI, Taiwan–(BUSINESS WIRE)–#CHIPSAct—TrendForce reports that the US Department of Commerce recently released details regarding its CHIPS and Science Act, which stipulates that...
GUANGZHOU, China–(BUSINESS WIRE)–#AACR–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced the company will present one poster concerning Phase 1...
HANOI, Vietnam–(BUSINESS WIRE)–#FPT–FPT Corporation (FPT) announced its business directions for 2023 onwards at the 2023 Annual General Meeting. The company highlighted a...
TOKYO–(BUSINESS WIRE)–Global AI Innovations Laboratory Co., Ltd. (hereinafter “GAILABO”) and AEON Financial Service Co., Ltd. (hereinafter “AFS”) have agreed to gradually introduce...